Related by context. Frequent words. (Click for all words.) 68 M2e 67 DermaVir 67 vivo electroporation 67 MVA BN R 66 TLR9 agonist 66 polyclonal antibody 66 nasal powder 66 GRNVAC1 65 GVAX R 65 CMV vaccine 65 tumor antigen 65 adenovector 65 VLP vaccine 64 highly immunogenic 64 prophylactic vaccine 64 immunomodulators 64 BiTE R 64 immunotherapeutics 63 humanized antibody 63 nanoviricides 63 neuraminidase inhibitor 62 Inovio Pharmaceuticals 62 Immunogenicity 62 Nanobody 62 Initiates Phase II 62 anti CD# monoclonal 62 live attenuated influenza 62 HPV cervical cancer 62 liposomal formulation 62 Hepatitis C HCV 62 Recombinant Human 62 Tarvacin TM 62 rPA 62 Panzem R 62 Respiratory Syncytial Virus RSV 62 monoclonal 61 immunostimulatory 61 PEG SN# 61 Inovio proprietary electroporation 61 VLPs 61 CEQ# 61 oncolytic 61 ALN TTR 61 Antigens 61 PEGylated 61 NY ESO 61 Interferons 61 lentiviral 61 RiVax ™ 61 proteasome inhibitor 61 nanoviricide 61 polyclonal 61 CCX# 61 REMUNE R 61 Belimumab 61 Factor VIIa 61 SNALP 61 prophylactic vaccines 60 particle VLP 60 Human papillomavirus 60 therapeutic monoclonal antibodies 60 Bavituximab 60 lentiviral vectors 60 recombinant vaccines 60 dependent cellular cytotoxicity 60 NanoViricides 60 adenoviral 60 Epratuzumab 60 theranostic 60 targeting CD# 60 cancer immunotherapies 60 lentiviral vector 60 chemokine receptor 60 Meets Primary Endpoint 60 Thiarabine 60 Mucosal 60 Alinia 60 Interferon alpha 60 Tumor Necrosis Factor 60 recombinant vaccine 60 diphtheria tetanus pertussis 60 humanized antibodies 59 Hybridon 59 TLR9 agonists 59 GV# [001] 59 DNA plasmid 59 Tesetaxel 59 Dapagliflozin 59 active cellular immunotherapy 59 Aliskiren 59 Monoclonal Antibody 59 synthetic peptides 59 Shigamabs ® 59 FDA Accepts 59 Valortim R 59 fusion inhibitor 59 VaxInnate 59 Copegus R 59 Daclizumab 59 Preclinical Data 59 SAR# [004]